# High tolerance does not mean protection

## What this article is about

“I can drink a lot and still seem normal.” “The substance I usually use barely has an effect.” Observations like these are sometimes taken as evidence of a strong constitution. Yet feeling an effect less, showing it less to other people, and being protected from harm are different things. Being able to “handle it” does not establish a safe amount or confirm good health.

This article is for adults who notice that a familiar effect has weakened or compare their tolerance with someone else's, and for those close to them. We will examine what tolerance means, why breaks and combinations change the situation, and which observations are useful to share with a professional. It offers no methods for building tolerance or testing a limit by using substances.

**If someone cannot be awakened, loses consciousness, or has unusually slow, shallow, or difficult breathing, contact the local emergency medical service immediately. Their previous tolerance does not explain away or remove this danger.** [CDC: opioid risks](https://www.cdc.gov/overdose-prevention/manage-treat-pain/reduce-risks.html), [NHS: alcohol poisoning](https://www.nhs.uk/conditions/alcohol-poisoning/).

## What tolerance means

Tolerance is a reduced response to a familiar exposure: more of a substance may be needed to produce a similar effect. In everyday language, the term also often includes a simply less noticeable reaction. But “I hardly feel drunk” does not establish how that characteristic developed. NIAAA distinguishes a low response to intoxicating effects from the development of tolerance; neither is described as protection. [NIAAA: questions and answers](https://rethinkingdrinking.niaaa.nih.gov/questions-answers).

It matters to clarify which effect has become weaker: perceived intoxication, relaxation, drowsiness, or another familiar effect. Without that clarification, “tolerance” can too easily become a general claim that “nothing is happening to me.” The observation is useful, but its medical meaning is considered alongside the history of use and the person's health.

You do not need to deliberately increase the amount, compare substances, or take a break followed by a trial to prove that tolerance exists. Reporting changes that have already happened is enough.

## How you feel, how you look, and risk are different

A person may feel less intoxicated or look more composed than someone else. That does not turn a feeling into a medical measurement. NIAAA warns that decision-making and driving skills can deteriorate long before physical signs of intoxication are obvious. Coherent speech, steady walking, and confidence therefore do not establish fitness to drive or undertake another hazardous activity. [NIAAA: questions and answers](https://rethinkingdrinking.niaaa.nih.gov/questions-answers).

Similarly, continuing to work shows that a person performs certain tasks, rather than that every consequence of substance use has been assessed. A feeling of productivity can be acknowledged while the quality of results, errors, health, and relationships are considered separately. There is no need to dismiss a positive experience as self-deception. The important point is to avoid concluding more from it than it shows.

Comparison with friends also does not establish protection. “Who will feel the effect first?” is different from “What is my risk in this situation?” The first compares reactions; the second requires other information.

## Why being able to “handle a lot” can increase risk

With a low response to alcohol, a person may drink more before noticing the feeling they expect. NIAAA associates this characteristic with an increased risk of alcohol use disorder; long-term problematic drinking can harm the liver, heart, and brain. This is increased risk, rather than a diagnosis or an inevitable outcome for an individual. [NIAAA: questions and answers](https://rethinkingdrinking.niaaa.nih.gov/questions-answers).

Consider a hypothetical example: someone is told they are “the strongest drinker” in a group. They take the absence of obvious intoxication as permission to continue. The mistake is not that they invented their feeling, but the move from “I do not feel much yet” to “therefore further use is safe.” The example illustrates a possible decision, rather than how often this behavior occurs.

A change in tolerance is useful information for reconsidering the situation. It is not an achievement to maintain by training the body. Both a high and a low noticeable response leave the question of harm open; lower tolerance also cannot be promised to provide protection.

## One sign does not establish addiction

Tolerance, physical dependence, withdrawal symptoms, and addiction are related but are not interchangeable. Assessment considers a pattern of behavior, such as difficulties controlling use and continuing despite harm. A single sign or the duration of use does not provide a complete diagnosis. [NIMH: substance use disorders](https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health).

The absence of a noticeable increase in tolerance does not establish that there is no problem either. A person may suffer consequences or lose freedom of choice even without describing a need for ever larger amounts. It is better to discuss specifics: what has changed, what has become more difficult, and what attempts to change use have already occurred.

Medicines need separate consideration. FDA notes that physical dependence on benzodiazepines can develop even when taken as prescribed; this class has therapeutic uses and substantial risks. That does not justify automatically labeling every patient as having addiction or treating all prescription medicines as identical. [FDA: benzodiazepines](https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class). Treatment is considered through its purpose, benefits, unwanted effects, and the clinician's plan, rather than a blanket label such as “pharmacy narcotics.”

## Past experience does not carry over unchanged after a break

This is especially important for opioids. After tolerance has been lost, returning to previous high-level use increases overdose risk; CDC specifically identifies this risk. A familiar past is not a current reserve of safety. [CDC: opioid risks](https://www.cdc.gov/overdose-prevention/manage-treat-pain/reduce-risks.html).

This article provides neither a period after which a return can be considered safe nor a calculation of an appropriate amount. Its purpose is to explain why “I used to tolerate it” is no longer a dependable rule, rather than to teach recalculation after a pause. This specific opioid overdose risk is not automatically assigned to every substance with the same mechanism and severity.

For a prescribed medicine, tell the professional about a break before restarting or changing treatment yourself. If a person is considering returning to substance use, risk and available help are matters to discuss now, rather than after testing the situation on themselves.

## Familiarity does not make combinations safe

Tolerance to one substance does not give permission to combine it with another. CDC warns about dangerous combinations of opioids with alcohol, benzodiazepines, and other medicines that cause drowsiness. Prescription medicines are also involved; coming from a pharmacy does not remove interactions. [CDC: opioid risks](https://www.cdc.gov/overdose-prevention/manage-treat-pain/reduce-risks.html).

Stimulant and depressant effects also do not form a reliable counterbalance. CDC explains that a combination can change or mask perceived effects and create the impression that a drug is not affecting you. This does not reduce the risk to a safe level. [CDC: polysubstance use](https://www.cdc.gov/stop-overdose/caring/polysubstance-use.html).

Another difficulty is an unknown composition: another substance may be present without the person's knowledge. [CDC: polysubstance use](https://www.cdc.gov/stop-overdose/caring/polysubstance-use.html). A familiar reaction or a seller's confidence cannot reliably assess that risk.

Do not add another product on your own to “balance out” your condition. Clinically prescribed combinations are discussed as a specific plan with known aims and monitoring; neither a blanket permission to mix nor a self-directed withdrawal of all treatment can replace that discussion.

## Putting this understanding to use

A useful step is to change the question from “How much can I handle?” to “What is happening to my substance use and health, and what help do I need?” Five short notes can help a conversation with a primary care clinician or addiction specialist. This is an editorial way of organizing observations, not a diagnostic scale.

1. **Changes in response:** what you used to feel, what has become weaker, and when you noticed it. Do not create a new trial to make the note.
2. **Pattern of use:** which substances and products are used, whether amounts or frequency have changed, and which prescriptions are current. Mark an unknown composition as unknown.
3. **Breaks and withdrawal:** what happened during past reductions, whether there were unpleasant or severe symptoms, and what support was provided.
4. **Consequences:** sleep, physical health, errors, relationships, responsibilities, and situations involving a threat to safety.
5. **Current question:** whether you want to understand risk, review treatment, reduce use, or get help stopping.

You might say: “The usual effect has become less noticeable. I took that to mean I was protected, but I want to assess the risks and understand how to discuss changes safely.”

Ask the professional what needs assessment now, which combinations matter in your history, whether withdrawal may need medical support, and who can help with the next stage of care. You do not have to wait until you lose the ability to work before seeking help. The general principles in this article do not establish a safe amount for an individual reader.

## Changing use also needs attention

Recognizing risk does not mean abruptly stopping without an assessment. With physical dependence on alcohol, sudden cessation can be dangerous; when withdrawal symptoms occur, seek medical help before attempting to stop on your own. Seizures, marked confusion, or hallucinations after reducing alcohol require immediate local emergency medical care. [NHS: alcohol-use disorder](https://www.nhs.uk/conditions/alcohol-use-disorder/).

FDA also warns about dangerous abrupt cessation and overly rapid reduction of benzodiazepines. An individual plan is discussed with the prescriber; this article provides no doses, rates of reduction, or home methods for restoring tolerance. [FDA: benzodiazepines](https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class).

A loved one can offer help seeking care and describe observations already made, with the person's agreement. Their role is not to test “how much the person can handle,” choose a dose, or treat a calm appearance as a guarantee. A child does not become a monitor or the person responsible for an adult's safety.

High tolerance provides information about a response to exposure. It is not medical insurance. A next step can begin with an honest description of changes and a discussion of care, without competition, shame, or attempts to prove that you are exceptional.

## Sources and basis

- NIAAA. [Rethinking Drinking: Questions & Answers](https://rethinkingdrinking.niaaa.nih.gov/questions-answers). The section on “holding your liquor”: low response, tolerance, risks, and early skill impairment.
- National Institute of Mental Health. [Finding Help for Co-Occurring Substance Use and Mental Disorders](https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health). Page reviewed March 2025. Patterns of disorder and comprehensive assessment.
- CDC. [Risks and How to Reduce Them](https://www.cdc.gov/overdose-prevention/manage-treat-pain/reduce-risks.html). 8 May 2024. Opioid risks, lost tolerance, combinations, and overdose signs.
- CDC. [Polysubstance Use Facts](https://www.cdc.gov/stop-overdose/caring/polysubstance-use.html). 2 April 2024. Masking of effects in combinations and unknown additional substances, without instructions for use.
- FDA. [Boxed Warning updated to improve safe use of benzodiazepine drug class](https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class). 23 September 2020. Therapeutic uses, distinct risks, and medically planned withdrawal.
- NHS. [Alcohol-use disorder](https://www.nhs.uk/conditions/alcohol-use-disorder/). Page reviewed 24 April 2026. Risks of abrupt cessation with dependence and urgent withdrawal signs.
- NHS. [Alcohol poisoning](https://www.nhs.uk/conditions/alcohol-poisoning/). Page reviewed 4 June 2026. Loss of consciousness and breathing problems as grounds for emergency help.

## Tags

Tolerance · alcohol · opioids · medicines · polysubstance use · overdose · physical dependence · medical care

## About the authors

Andrey Zarinsh is the author and founder of United Wisdom. He explores inner transformation, the unity of traditions, intercultural dialogue, and contemporary spiritual discipline. Instagram: @andrey.zarinsh.

Maria Evilkut is a co-author of United Wisdom. Alongside her research, she seeks to put these ideas into practice and observe how the principles of unity and mutual understanding work in real life between people and cultures. Instagram: @ilkutki.

Language version: English. Content review date: 14 October 2026.